chr8-27463456-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_000742.4(CHRNA2):c.987C>T(p.Gly329Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000315 in 1,614,090 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00050 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00030 ( 2 hom. )
Consequence
CHRNA2
NM_000742.4 synonymous
NM_000742.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.280
Genes affected
CHRNA2 (HGNC:1956): (cholinergic receptor nicotinic alpha 2 subunit) Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 8-27463456-G-A is Benign according to our data. Variant chr8-27463456-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 204990.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS2
High AC in GnomAd4 at 76 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA2 | NM_000742.4 | c.987C>T | p.Gly329Gly | synonymous_variant | 6/7 | ENST00000407991.3 | NP_000733.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNA2 | ENST00000407991.3 | c.987C>T | p.Gly329Gly | synonymous_variant | 6/7 | 5 | NM_000742.4 | ENSP00000385026.1 |
Frequencies
GnomAD3 genomes AF: 0.000499 AC: 76AN: 152218Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
76
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000597 AC: 150AN: 251396Hom.: 0 AF XY: 0.000545 AC XY: 74AN XY: 135890
GnomAD3 exomes
AF:
AC:
150
AN:
251396
Hom.:
AF XY:
AC XY:
74
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000296 AC: 433AN: 1461872Hom.: 2 Cov.: 33 AF XY: 0.000278 AC XY: 202AN XY: 727240
GnomAD4 exome
AF:
AC:
433
AN:
1461872
Hom.:
Cov.:
33
AF XY:
AC XY:
202
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000499 AC: 76AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.000740 AC XY: 55AN XY: 74366
GnomAD4 genome
AF:
AC:
76
AN:
152218
Hom.:
Cov.:
33
AF XY:
AC XY:
55
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 26, 2014 | p.Gly329Gly (G329G) GGC>GGT: c.987 C>T in exon 6 of the CHRNA2 gene (NM_000742.3). The c.987 C>T variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The c.987 C>T variant was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. Multiple in silico algorithms predict that c.987 C>T could potentially create a cryptic donor site in exon 6 that may supplant the natural donor site. However, to our knowledge, no splice mutations have been reported in the CHRNA2 gene, and in the absence of RNA/functional studies, the actual effect of c.987 C>T is unknown. The variant is found in EPILEPSY panel(s). - |
Autosomal dominant nocturnal frontal lobe epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at